OPRX News and Press, OptimizeRx Corporation From 11/09/22

OptimizeRx Corporation (OPRX) Q3 2022 Earnings Conference Call November 8, 2022 16:30 ET Company Participants Will Febbo - Chief Executive Officer Ed Stelmakh - Chief Financial and Operating Officer Steve Silvestro - Chief Commercial Officer Marion Odence-For...

OptimizeRx press release ( NASDAQ: OPRX ): Q3 Non-GAAP EPS of $0.07 beats by $0.03 . Revenue of $15.1M (-6.3% Y/Y) beats by $0.08M . Gross profit in the third quarter of 2022 increased 4% year-over-year to $9.4 million. Cash, cash equivalents and short-term...

Q3 Revenue of $15.1 million, down 6% year-over-year and up 8% quarter-over-quarter Gross profit increased 4% year-over-year to $9.4 million as gross margins increased from 56% to 62% Generated $7.9 million in cash flow from operations during the first nine months of 2022 Rep...

OptimizeRx ( NASDAQ: OPRX ) is scheduled to announce Q3 earnings results on Tuesday, November 8th, after market close. The consensus EPS Estimate is $0.04 (-55.6% Y/Y) and the consensus Revenue Estimate is $15.02M (-6.8% Y/Y). Over the last 2 years, OPRX has beaten E...

Summary Shares of digital healthcare marketing firm OptimizeRx Corporation have cratered 86% in just 11 months as an initial FY22 revenue growth projection has been revised from 35% to 6%. A slowdown in FDA approvals has been blamed, but the stock was wildly overvalued, trading at...

ROCHESTER, Mich., Oct. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced the third annual Innovate4Outcomes ® event...

ROCHESTER, Mich., Oct. 19, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Tuesday, November 8, 202...

Summary OptimizeRx has lost roughly 83% over the past twelve months despite showing impressive growth and profitability metrics. The market-wide sell-off is providing an opportunity to establish a position in OPRX. The company is expected to report double-digit growth over the nex...

ROCHESTER, Mich., Oct. 11, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy announced results from a recent program that used its patent-...

Innovative best-in-class technology solutions continue to offer HCPs a seamless prescribing experience within the EHR workflow ROCHESTER, Mich., Sept. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of poi...